Trade BCRX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
BioCryst Pharmaceuticals, Inc. (BCRX) is trading at US$8.24, down 3.85% today as of Nov 4, 16:00 EST. The company has a market capitalisation of US$2.44B. Over the past 52 weeks, BCRX has traded between US$6.23 and US$11.22. On Syfe you can trade BCRX with $0 commission and add it to your watchlist.
| Previous close | US$8.57 |
|---|---|
| Market cap | US$2.44B |
| P/E ratio | 73.17 |
| 52-week range | US$6.23 – US$11.22 |
| Volume | 10.2M |
| Exchange | US |
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Year: 1994
BioCryst Pharmaceuticals, Inc. (BCRX) stock is trading at US$8.24, -3.85% from the previous close of US$8.57.
The market cap for BioCryst Pharmaceuticals, Inc. (BCRX) stock is approximately US$2.44B.
The price-to-earnings ratio for BioCryst Pharmaceuticals, Inc. (BCRX) is 73.17, based on the latest reported earnings.
The 52-week high for BioCryst Pharmaceuticals, Inc. (BCRX) stock is US$11.22.
The 52-week low for BioCryst Pharmaceuticals, Inc. (BCRX) stock is US$6.23.
BioCryst Pharmaceuticals, Inc. (BCRX) does not currently pay a dividend.
Stay on top of BCRX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
